Pheno- and genotype correlation analysis in Duchenne/Becker progressive myopathies, in cystic fibrosis and galactosemia

A. Laszlo, E. Endreffy, Z. Havass, A. Szabo, I. Raskó, Y. Shin, J. J. Elsas

Research output: Contribution to journalArticle

Abstract

The correlation between the pheno- and genotype was studied in Duchenne/Becker myopathies. Molecular genetic analysis for 18 exons of dystrophin gene and promoter gene was carried out in 78 patients with PCR method. In multiple PCR for exons 8, 17, 19, 44, 45, 48 and for exons 4, 12, 51 was performed as described by Chamberlain et al. (1), whereas for muscle specific promoter (Pm), 3, 6, 13, 43, 47, 50, 52, 60 and 49 exons by Beggs' method (2). Promega Taq DNA polymerase enzyme and Boehringer dNTPs were used for the amplification reaction. The PCR products were kept at 4C before analysis and were analysed by 12% non-denaturing polyacrylamide gel electrophoresis. After staining the gel with ethidium bromide, the visible DNA-strands corresponding to the different amplified products were photographed. Results: 35 out of 78 patients had exonal deletions (45%). The most frequent deletions involved the 47-48-49-50 exons. 85% of exonal deletions occurred at the 3' end of the gene In Duchenne muscular dystrophic (DMD) and intermediate cases mostly out of frame deletions occurred, while in Becker muscular dystrophic (BMD) patients the majority of the deletions were in frame type. There was no correlation between the extension of the deletions and the clinical severity and IQ. The in-frame or out-of-frame character of the deletion was responsible for the clinical phenotype.

Original languageEnglish
Pages (from-to)88-90
Number of pages3
JournalPaediatria Croatica
Volume39
Issue number2
Publication statusPublished - 1995

Fingerprint

Galactosemias
Genetic Association Studies
Muscular Diseases
Cystic Fibrosis
Exons
Frameshift Mutation
Polymerase Chain Reaction
Taq Polymerase
Genes
Native Polyacrylamide Gel Electrophoresis
Dystrophin
Ethidium
Molecular Biology
Gels
Staining and Labeling
Phenotype
Muscles
DNA
Enzymes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pheno- and genotype correlation analysis in Duchenne/Becker progressive myopathies, in cystic fibrosis and galactosemia. / Laszlo, A.; Endreffy, E.; Havass, Z.; Szabo, A.; Raskó, I.; Shin, Y.; Elsas, J. J.

In: Paediatria Croatica, Vol. 39, No. 2, 1995, p. 88-90.

Research output: Contribution to journalArticle

@article{39898020ae1a4f03bc1c7352391120ef,
title = "Pheno- and genotype correlation analysis in Duchenne/Becker progressive myopathies, in cystic fibrosis and galactosemia",
abstract = "The correlation between the pheno- and genotype was studied in Duchenne/Becker myopathies. Molecular genetic analysis for 18 exons of dystrophin gene and promoter gene was carried out in 78 patients with PCR method. In multiple PCR for exons 8, 17, 19, 44, 45, 48 and for exons 4, 12, 51 was performed as described by Chamberlain et al. (1), whereas for muscle specific promoter (Pm), 3, 6, 13, 43, 47, 50, 52, 60 and 49 exons by Beggs' method (2). Promega Taq DNA polymerase enzyme and Boehringer dNTPs were used for the amplification reaction. The PCR products were kept at 4C before analysis and were analysed by 12{\%} non-denaturing polyacrylamide gel electrophoresis. After staining the gel with ethidium bromide, the visible DNA-strands corresponding to the different amplified products were photographed. Results: 35 out of 78 patients had exonal deletions (45{\%}). The most frequent deletions involved the 47-48-49-50 exons. 85{\%} of exonal deletions occurred at the 3' end of the gene In Duchenne muscular dystrophic (DMD) and intermediate cases mostly out of frame deletions occurred, while in Becker muscular dystrophic (BMD) patients the majority of the deletions were in frame type. There was no correlation between the extension of the deletions and the clinical severity and IQ. The in-frame or out-of-frame character of the deletion was responsible for the clinical phenotype.",
author = "A. Laszlo and E. Endreffy and Z. Havass and A. Szabo and I. Rask{\'o} and Y. Shin and Elsas, {J. J.}",
year = "1995",
language = "English",
volume = "39",
pages = "88--90",
journal = "Paediatria Croatica",
issn = "1330-1403",
publisher = "Children's Hospital Zagreb",
number = "2",

}

TY - JOUR

T1 - Pheno- and genotype correlation analysis in Duchenne/Becker progressive myopathies, in cystic fibrosis and galactosemia

AU - Laszlo, A.

AU - Endreffy, E.

AU - Havass, Z.

AU - Szabo, A.

AU - Raskó, I.

AU - Shin, Y.

AU - Elsas, J. J.

PY - 1995

Y1 - 1995

N2 - The correlation between the pheno- and genotype was studied in Duchenne/Becker myopathies. Molecular genetic analysis for 18 exons of dystrophin gene and promoter gene was carried out in 78 patients with PCR method. In multiple PCR for exons 8, 17, 19, 44, 45, 48 and for exons 4, 12, 51 was performed as described by Chamberlain et al. (1), whereas for muscle specific promoter (Pm), 3, 6, 13, 43, 47, 50, 52, 60 and 49 exons by Beggs' method (2). Promega Taq DNA polymerase enzyme and Boehringer dNTPs were used for the amplification reaction. The PCR products were kept at 4C before analysis and were analysed by 12% non-denaturing polyacrylamide gel electrophoresis. After staining the gel with ethidium bromide, the visible DNA-strands corresponding to the different amplified products were photographed. Results: 35 out of 78 patients had exonal deletions (45%). The most frequent deletions involved the 47-48-49-50 exons. 85% of exonal deletions occurred at the 3' end of the gene In Duchenne muscular dystrophic (DMD) and intermediate cases mostly out of frame deletions occurred, while in Becker muscular dystrophic (BMD) patients the majority of the deletions were in frame type. There was no correlation between the extension of the deletions and the clinical severity and IQ. The in-frame or out-of-frame character of the deletion was responsible for the clinical phenotype.

AB - The correlation between the pheno- and genotype was studied in Duchenne/Becker myopathies. Molecular genetic analysis for 18 exons of dystrophin gene and promoter gene was carried out in 78 patients with PCR method. In multiple PCR for exons 8, 17, 19, 44, 45, 48 and for exons 4, 12, 51 was performed as described by Chamberlain et al. (1), whereas for muscle specific promoter (Pm), 3, 6, 13, 43, 47, 50, 52, 60 and 49 exons by Beggs' method (2). Promega Taq DNA polymerase enzyme and Boehringer dNTPs were used for the amplification reaction. The PCR products were kept at 4C before analysis and were analysed by 12% non-denaturing polyacrylamide gel electrophoresis. After staining the gel with ethidium bromide, the visible DNA-strands corresponding to the different amplified products were photographed. Results: 35 out of 78 patients had exonal deletions (45%). The most frequent deletions involved the 47-48-49-50 exons. 85% of exonal deletions occurred at the 3' end of the gene In Duchenne muscular dystrophic (DMD) and intermediate cases mostly out of frame deletions occurred, while in Becker muscular dystrophic (BMD) patients the majority of the deletions were in frame type. There was no correlation between the extension of the deletions and the clinical severity and IQ. The in-frame or out-of-frame character of the deletion was responsible for the clinical phenotype.

UR - http://www.scopus.com/inward/record.url?scp=0028999293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028999293&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 88

EP - 90

JO - Paediatria Croatica

JF - Paediatria Croatica

SN - 1330-1403

IS - 2

ER -